Provided by Tiger Fintech (Singapore) Pte. Ltd.

Apogee Therapeutics

40.12
+0.92002.35%
Post-market: 40.120.00000.00%16:05 EDT
Volume:616.31K
Turnover:24.89M
Market Cap:2.33B
PE:-12.16
High:41.05
Open:39.90
Low:39.24
Close:39.20
Loading ...
Oct 24, 2024

Major Issues Report

Form 8-K - Current report
Oct 04, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Oct 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 19, 2024

Major Issues Report

Form 8-K - Current report
Aug 12, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 12, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 12, 2024

Major Issues Report

Form 8-K - Current report
Aug 07, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 07, 2024

Major Issues Report

Form 8-K - Current report
May 28, 2024

Major Issues Report

Form 8-K - Current report
May 15, 2024

Major Issues Report

Form 8-K - Current report
May 13, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 13, 2024

Major Issues Report

Form 8-K - Current report
Apr 01, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]